Filing Details
- Accession Number:
- 0001193805-22-000800
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-16 08:30:27
- Reporting Period:
- 2022-05-12
- Accepted Time:
- 2022-05-16 08:30:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1280776 | Immunic Inc. | IMUX | Pharmaceutical Preparations (2834) | 562358443 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1850468 | Andreas Muehler | 1200 Avenue Of The Americas Suite 200 New York City NY 10036 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-12 | 3,500 | $5.10 | 297,986 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Consists of 13,506 shares of common stock held directly by the Reporting Person and 284,480 shares of common stock held indirectly by Xanomed GmbH, an entity controlled by the Reporting Person.
Billionaire Hedge Funds
